On April 10, 2024, Zoetis Inc announced that it has filed a definitive proxy statement with Securities and Exchange Commission, stating that it has received a shareholder proposal from John Chevedden, regarding to adopt a Corporate Governance Guideline, rule or bylaw provision to state that that a director who fails to obtain a majority vote in an uncontested election shall not be nominated by the Board at the next annual shareholder meeting. In addition, the Company recommended the shareholders to vote against the proposal at the annual meeting of shareholders scheduled to be held on May 22, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.7 USD | +0.81% | +9.73% | -19.09% |
Apr. 29 | Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million | DJ |
Apr. 29 | Zoetis to Sell Medicated Feed Additives Business to Phibro Animal Health for $350 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.09% | 72.39B | |
-8.93% | 6.54B | |
+21.38% | 3.43B | |
+1.52% | 1.4B | |
-16.99% | 1.34B | |
-3.81% | 1.26B | |
-26.05% | 1.2B | |
-12.71% | 1.12B | |
-4.03% | 990M | |
-23.05% | 805M |
- Stock Market
- Equities
- ZTS Stock
- News Zoetis Inc.
- Zoetis Inc Files a Definitive Proxy Statement with Securities and Exchange Commission